|
Orthologous residues
|
|
PTPRA (human): Y798‑p, PTPRA iso2 (human): Y789‑p, PTPRA (mouse): Y825‑p, PTPRA (rat): Y792‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
phospho-antibody, western blotting
|
|
Relevant cell lines - cell types - tissues:
293 (epithelial), endothelial-aorta, HUVEC (endothelial), MEF (fibroblast)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
H2O2
|
|
|
|
inhibit treatment-induced decrease
|
H2O2 inhibits ST789 phosphorylation in various cell lines and is dose-dependent.
|
|
GF109203X, rottlerin, BAPTA-AM, PP1
|
H2O2
|
|
|
augment treatment-induced decrease
|
PP1 and other inhibitors inhibit T789 phosphorylation alone and when treated with H2O2.
|
|
|
|